PSORALIDIN
UNII G16ZUQ069L

Substance Identification & Data

This profile provides standardized clinical and technical data for Psoralidin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) G16ZUQ069L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 18642-23-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
G16ZUQ069L
CAS Registry Number
18642-23-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
PSORALIDIN
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C20H16O5
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
YABIJLLNNFURIJ-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
O=c1oc2cc(O)c(CC=C(C)C)cc2c3oc4cc(O)ccc4c31

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Psoralidin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

PSORALIDIN
PSORALIDIN [MI]

Systematic Nomenclature

3-BENZOFURANCARBOXYLIC ACID, 2-(2,4-DIHYDROXY-5-(3-METHYL-2-BUTENYL)PHENYL)-6-HYDROXY-, .DELTA.-LACTONE
6H-BENZOFURO(3,2-C)(1)BENZOPYRAN-6-ONE, 3,9-DIHYDROXY-2-(3-METHYL-2-BUTENYL)-